Article Public (all visitors)

Alzheimer’s Treatments Showing Early Promise

AARP 2021
Resources from AARP
Bookmark this resource View Original Source

A small study has found that the experimental drug donanemab may slow cognitive decline in Alzheimer's patients. It joins others that show promise.

Placed in

Where this Article is used

Keep exploring

Related resources

More to explore from shared collections and topics.

Contribute to BackpackerU Resources

Found something worth adding?

Sign in to suggest resources and start organizing your own travel-learning library.

Log in to suggest Create account